Glaxo to buy Stiefel Labs for up to $3.6 billion
Monday, April 20, 2009 : PermalinkReuters UK – GlaxoSmithKline Plc, the world’s second-largest drugmaker, has agreed to buy privately owned U.S. skincare specialist Stiefel Laboratories Inc for up to $3.6 billion, the two companies said on Monday.
The acquisition is the latest in a string of deals in the drugs sector, but is significantly smaller than recent mega-mergers, reflecting the British-based group’s declared focus on bolt-on buys to diversify its business.
Tags: acquisition, bolt, drugs, glaxosmithkline, glaxosmithkline plc, laboratories inc, mergers, reuters, skincare
trackback from your site.
